Search - tctmd.com

Displaying 241 - 260 of 334

Sort: Relevancy | Date

News Daily News

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Yael L. Maxwell

January 09, 2014

News Daily News

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Yael L. Maxwell

January 09, 2014

Presentation

Detection and Treatment of Vulnerable Plaque: PROSPECT II and PROSPECT ABSORB

Presenter: Gregg W. Stone

December 02, 2013

Presentation

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

Presenter: Richard J. Rapoza

December 02, 2013

Presentation TCT 2013

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Presenter: Gregg Stone

October 30, 2013

News Conference News TCT 2013

Innovation in Intervention: Perspectives from Industry

October 30, 2013

Presentation TCT 2013

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

Presenter: JM White

October 29, 2013

Presentation TCT 2013

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

Presenter: Takashi Muramatsu

October 29, 2013

Presentation TCT 2013

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

Presenter: Yoshinobu Onuma

October 29, 2013

Presentation TCT 2013

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

Presenter: Bernard Chevalier

October 29, 2013

Presentation TCT 2013

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

Presenter: Robert Whitbourn

October 29, 2013

News Industry News

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

October 29, 2013

News Industry News

MiStent SES Shown to be Unique in Clinical Setting

October 29, 2013

Presentation TCT 2013

2 Cases: Absorb in a Distal Left Main Bifurcation and a Non Left Main Bifurcation

Presenter: Antonio Colombo

October 28, 2013

News Industry News

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

October 28, 2013

News Conference News TCT 2013

Bioresorbable Scaffold Stands Ground Next to Current DES

October 28, 2013

News Conference News TCT 2013

ABSORB III and IV Trials Aim to Prove Superiority of BVS

October 28, 2013

Presentation TCT 2013

Is ABSORB a Workhorse DES? Real-world Perspectives I

Presenter: Antonio Colombo

October 27, 2013

Presentation TCT 2013

The ABSORB III trial: Design, Goals and Enrollment Status

Presenter: Stephen Ellis

October 27, 2013

Presentation TCT 2013

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Presenter: Richard Rapoza

October 27, 2013

Advertisement

Los Andamiajes Bioabsorbibles resultan Prometedores en Pacientes STEMI Seleccionados

Bioresorbable Scaffolds Show Promise in Select STEMI Patients

Detection and Treatment of Vulnerable Plaque: PROSPECT II and PROSPECT ABSORB

Absorb Bioresorbable Vascular Scaffold System - (NEW) ABCs of Bioabsorbable Polymeric Scaffolds

Rationale for Bioresorbable Vascular Scaffolds as a VP Shield: The PROSPECT ABSORB Trial

Innovation in Intervention: Perspectives from Industry

Bifurcation Strategies with the Absorb BVS Everolimus-Eluting Resorbable Scaffold: A Bench Study

TCT-36. One-year Clinical Outcomes of Diabetic Patients Treated With Everolimus-Eluting Bioresorbable Vascular Scaffolds: A Pooled Analysis From the ABSORB Cohort B and the ABSO...

TCT-34. The appearance of jailed side branches post-procedure, at 6, 12, 24 and 36 months following implantation of bioresorbable vascular devices – Insights from the ABSORB...

TCT-32. First Report of the Four Year Clinical Results of The ABSORB Trial Evaluating the Absorb Everolimus Eluting Bioresorbable Vascular Scaffold in the Treatment of Patients...

TCT-31. ABSORB EXTEND: An Interim Report on the 24-month Clinical Outcomes from the First 250 Patients Enrolled

Global Bifurcation Leader Tryton Medical Announces Events at TCT 2013

MiStent SES Shown to be Unique in Clinical Setting

2 Cases: Absorb in a Distal Left Main Bifurcation and a Non Left Main Bifurcation

CRF and UCR Announce Initiation of PROSPECT II Clinical Trial

Bioresorbable Scaffold Stands Ground Next to Current DES

ABSORB III and IV Trials Aim to Prove Superiority of BVS

Is ABSORB a Workhorse DES? Real-world Perspectives I

The ABSORB III trial: Design, Goals and Enrollment Status

Polylactic Acid Polymers: Chemistry and Structure in ABSORB 1.0 and 1.1

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content